2.160USD-2.70%Mkt Cap: 23.18M $P/E: —1d ago
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hype…
Industry Peers
Drug Manufacturers - Specialty & Generic$64.41BUSDP/E 23.3
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.40BUSDP/E 118.1
$14.51BUSDP/E 30.3
$12.96BUSD
$9.04BUSDP/E 23.0
$7.80BUSD
$6.84BUSDP/E 25.1
$6.69BUSDP/E 442.8
$5.76BUSDP/E 48.8
$3.69BUSDP/E 19.2
$3.57BUSDP/E 11.4
$3.01BUSDP/E 21.0
$2.80BUSD
$2.53BUSDP/E 56.2
$2.33BUSDP/E 16.1
$2.40BUSDP/E 12.9
$2.31BUSD
$1.90BUSDP/E 19.2
$1.89BUSD
$1.86BUSDP/E 21.0
$1.89BUSD
$1.57BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.21BUSDP/E 38.0
$1.18BUSDP/E 17.6
$1.20BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$1.01BUSDP/E 196.9
$985.07MUSD
$902.17MUSDP/E 14.5
$883.62MUSDP/E 38.6
$875.69MUSDP/E 12.0
$819.46MUSDP/E Infinity
$664.05MUSD
$692.84MUSDP/E 161.5
$637.05MUSDP/E 6.2
$503.88MUSDP/E 14.2
$494.34MUSD
$463.93MUSD
$427.80MUSD
$396.78MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$319.75MUSDP/E 43.6
$351.79MUSD
$303.08MUSDP/E 9.7
$285.23MUSD
$267.31MUSDP/E 48.0
$280.94MUSDP/E 14.5
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$233.72MUSDP/E 52.4
$207.94MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.51MUSDP/E 18.3
$146.07MUSD
$132.34MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$85.39MUSDP/E 12.3
$94.75MUSD
$72.08MUSD
$65.22MUSD
$70.06MUSD
$63.45MUSDP/E 29.2
$60.45MUSDP/E 51.0
$63.41MUSD
$53.24MUSD
$52.01MUSD
$51.08MUSD
$49.45MUSD
$48.31MUSD
$41.74MUSD
$33.86MUSDP/E Infinity
$37.20MUSD
$31.62MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$22.62MUSD
$22.15MUSD
$18.78MUSD
$17.65MUSD
$14.93MUSD
$13.64MUSDP/E 16.6
$14.21MUSD
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.51MUSDP/E 4.0
$6.35MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$1.93MUSD
$2.08MUSDP/E 35.5
$1.85MUSD
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap23.18M $
Enterprise Value20.05M $
Revenue (TTM)56.60M $
Gross Profit45.83M $
Net Income (TTM)-13.56M $
Revenue/Share6.158 USD
Last Price2.160 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees82
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS0547548588
Valuation
P/E (Trailing)—
P/E (Forward)-28.80
PEG—
EV/EBITDA-7.64
EV/Revenue0.35
P/S0.41
P/B0.66
EPS (TTM)-4.61
EPS (Forward)-0.07
52W Range
1.65036% of range3.070
52W High3.070 USD
52W Low1.650 USD
Profitability
Gross Margin69.04%
Oper. Margin-32.74%
EBITDA Margin-4.64%
Profit Margin-20.43%
ROE-71.51%
ROA-10.92%
Growth
Revenue Growth-32.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.94M $
CapEx (TTM)3.23M $
FCF Margin-2.11%
FCF Yield-5.15%
Net Debt-3.78M $
Net Debt/EBITDA1.44
Balance Sheet
Debt/Equity1.15
Current Ratio1.12
Quick Ratio0.85
Book Value/Sh3.274 USD
Cash/Share2.489 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 9, 2020
Splits
Last Split1:20
Split DateJan 6, 2023
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)9.500 USD
Upside (mean)+339.8%
Target Range7.000 USD – 14.50 USD
$7.000+339.8% to mean$14.50
# Analysts3
Ownership
Shares Out.10.73M
Float7.63M
Insiders8.98%
Institutions36.77%
Short Interest
Short Ratio11.7d
Short % Float3.78%
Short % Out.3.25%
Shares Short348.50K
Short (prev mo.)407.98K
Technical
SMA 502.232 (-3.2%)
SMA 2002.366 (-8.7%)
Beta0.25
S&P 52W Chg20.25%
Avg Vol (30d)25.25K
Avg Vol (10d)21.98K
Technical Indicators
RSI (14)45.8
MACD-0.0104
MACD Signal-0.0146
MACD Hist.+0.0042
BB Upper2.299 USD
BB Middle2.192 USD
BB Lower2.085 USD
BB Width9.76%
ATR (14)0.0821 USD
Vol Ratio (20d)1.39x